Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03769025 · ClinicalTrials.gov registry record · Phase 1

Remote Observed Dosing of Suboxone to Improve Clinical Practice

A Phase 1 study of Opioid Use Disorder and Opioid Dependence, sponsored by University of Pennsylvania.

Completed
Registry status
Phase 1
Development phase
16
Enrollment target
1
Study location

NCT03769025 is a Phase 1 study of Opioid Use Disorder and Opioid Dependence that has completed, run by University of Pennsylvania. The registered enrollment target is 16 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03769025, a Phase 1 study of Opioid Use Disorder and Opioid Dependence, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
Phase 1
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This is a 15-week, outpatient study of remote observed dosing to improve suboxone compliance in opiate dependent subjects.The main purpose of this study is to see if watching patients take their medication will improve treatment of opiate dependence by prompting patients to take all prescribed doses of Suboxone. Suboxone is approved by the Food and Drug Administration (FDA) for the treatment of opiate dependence. All patients receive a smartphone and patients in the intervention (remote observed dosing) group will use the smartphone to take videos of themselves taking Suboxone.

Conditions Studied

Opioid Use Disorder Opioid Dependence Opiate Dependence

Interventions

  • BEHAVIORAL Suboxone Remote Observed Dosing
  • OTHER Suboxone Attention Control

Study Locations (1)

Pennsylvania

  • University of Pennsylvania Treatment Research Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2019-04-01
Est. Completion 2022-07-01
Phase Phase 1

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03769025

The ClinicalTrials.gov registry entry for NCT03769025 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Suboxone Remote Observed Dosing is the first listed.

NCT03769025 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03769025 about?

NCT03769025 is a clinical study titled "Remote Observed Dosing of Suboxone to Improve Clinical Practice". This is a 15-week, outpatient study of remote observed dosing to improve suboxone compliance in opiate dependent subjects.The main purpose of this study is to see if watching patients take their medication will improve treatment of opiate dependence by prompting patients to take all prescribed doses...

What is the current status of trial NCT03769025?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2019-04-01. Estimated completion is 2022-07-01.

What conditions does trial NCT03769025 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Dependence, Opiate Dependence.

What interventions are being tested in trial NCT03769025?

The interventions under investigation include: Suboxone Remote Observed Dosing (BEHAVIORAL), Suboxone Attention Control (OTHER).

Who is sponsoring clinical trial NCT03769025?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03769025 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Opioid Dependence

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.